Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 6-7, Juin–Juillet 2014
Page(s) 644 - 650
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20143006014
Publié en ligne 11 juillet 2014
  1. Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006 ; 12 : 731–746. [CrossRef] [PubMed]
  2. Gellersen B, Brosens IA, Brosens JJ. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med 2007 ; 25 : 445–453. [CrossRef] [PubMed]
  3. Le Bouteiller P, Tabiasco J. Immunologie de la grossesse : faits nouveaux. Med Sci (Paris) 2006 ; 22 : 745–750. [CrossRef] [EDP Sciences] [PubMed]
  4. Ledee N, Chaouat G, Serazin V, et al. Endometrial vascularity by three-dimensional power Doppler ultrasound and cytokines: a complementary approach to assess uterine receptivity. J Reprod Immunol 2008 ; 77 : 57–62. [CrossRef] [PubMed]
  5. Chaouat G, Ledee-Bataille N, Dubanchet S, et al. TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 2004 ; 134 : 93–119. [CrossRef] [PubMed]
  6. Veenstra van Nieuwenhoven AL, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum Reprod Update 2003 ; 9 : 347–357. [CrossRef] [PubMed]
  7. Guzeloglu-Kayisli O, Kayisli UA, Taylor HS. The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med 2009 ; 27 : 62–79. [CrossRef] [PubMed]
  8. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity 2013 ; 39 : 1003–1018. [CrossRef] [PubMed]
  9. Dinarello CA, Novick D, Kim S, Kaplanski G., Interleukin-18, IL-18 binding protein. Front Immunol, ; 2013 ; 4 : 289.
  10. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011 ; 117 : 3720–3732. [CrossRef] [PubMed]
  11. Yoshino O, Osuga Y, Koga K, et al. Evidence for the expression of interleukin (IL)-18, IL-18 receptor and IL-18 binding protein in the human endometrium. Mol Hum Reprod 2001 ; 7 : 649–654. [CrossRef] [PubMed]
  12. Bigonnesse F, Labelle Y, Akoum A. Triphasic expression of interleukin-1 receptor type I in human endometrium throughout the menstrual cycle of fertile women and women with unexplained infertility. Fertil Steril 2001 ; 75 : 79–87. [CrossRef] [PubMed]
  13. Boucher A, Kharfi A, Al-Akoum M, et al. Cycle-dependent expression of interleukin-1 receptor type II in the human endometrium. Biol Reprod 2001 ; 65 : 890–898. [CrossRef] [PubMed]
  14. Carmi Y, Voronov E, Dotan S, et al. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol 2009 ; 183 : 4705–4714. [CrossRef] [PubMed]
  15. Saccani S, Pantano S, Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 2002 ; 3 : 69–75. [CrossRef] [PubMed]
  16. Rossi M, Sharkey AM, Vigano P, et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction 2005 ; 130 : 721–729. [CrossRef] [PubMed]
  17. Smith SK. Angiogenesis, vascular endothelial growth factor and the endometrium. Hum Reprod Update 1998 ; 4 : 509–519. [CrossRef] [PubMed]
  18. Edwards RG. Physiological and molecular aspects of human implantation. Hum Reprod 1995 ; 10 Suppl 2 : 1–13. [CrossRef] [PubMed]
  19. Bourdiec A, Shao R, Rao CV, Akoum A., Human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation. Biol Reprod 2012 ; 87 : 66. [CrossRef] [PubMed]
  20. Ledee-Bataille N, Dubanchet S, Coulomb-L’hermine A, et al. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004 ; 81 : 59–65. [CrossRef] [PubMed]
  21. Croy BA, Esadeg S, Chantakru S, et al. Update on pathways regulating the activation of uterine Natural Killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J Reprod Immunol 2003 ; 59 : 175–191. [CrossRef] [PubMed]
  22. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006 ; 27 : 399–404. [CrossRef]
  23. Simon C, Gimeno MJ, Mercader A, et al. Embryonic regulation of integrins beta 3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro. J Clin Endocrinol Metab 1997 ; 82 : 2607–2616. [PubMed]
  24. Prutsch N, Fock V, Haslinger P, et al. The role of interleukin-1beta in human trophoblast motility. Placenta 2012 ; 33 : 696–703. [CrossRef] [PubMed]
  25. Sheth KV, Roca GL, al-Sedairy ST, et al. Prediction of successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive factor(s) in preimplantation embryo culture fluid. Fertil Steril 1991 ; 55 : 952–957. [PubMed]
  26. Von Wolff M, Thaler CJ, Strowitzki T, et al. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod 2000 ; 6 : 627–634. [CrossRef] [PubMed]
  27. Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update 2010 ; 16 : 510–524. [CrossRef] [PubMed]
  28. Lee SK, Kim JY, Lee M, et al. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 2012 ; 67 : 311–318. [CrossRef] [PubMed]
  29. Zenclussen AC. Adaptive immune responses during pregnancy. Am J Reprod Immunol 2013 ; 69 : 291–303. [CrossRef] [PubMed]
  30. Chaouat G. Inflammation, NK cells and implantation: friend and foe (the good, the bad and the ugly?): replacing placental viviparity in an evolutionary perspective. J Reprod Immunol 2013 ; 97 : 2–13. [CrossRef] [PubMed]
  31. Ledee-Bataille N, Bonnet-Chea K, Hosny G, et al. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril 2005 ; 83 : 598–605. [CrossRef] [PubMed]
  32. Wang ZC, Yunis EJ, De los Santos MJ, et al. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes Immun 2002 ; 3 : 38–42. [CrossRef] [PubMed]
  33. Perni SC, Vardhana S, Tuttle SL, et al. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin-1beta levels, and history of spontaneous abortion. Am J Obstet Gynecol 2004 ; 191 : 1318–1323. [CrossRef] [PubMed]
  34. Gremlich S, Fratta S, Rebellato E, et al. Interleukin-1 receptor antagonist gene (IL-1RN) polymorphism is a predictive factor of clinical pregnancy after IVF. Hum Reprod 2008 ; 23 : 1200–1206. [CrossRef] [PubMed]
  35. Unfried G, Tempfer C, Schneeberger C, et al. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 2001 ; 75 : 683–687. [CrossRef] [PubMed]
  36. Chaves JH, Babayan A, Bezerra Cde M, et al. Maternal and neonatal interleukin-1 receptor antagonist genotype and pregnancy outcome in a population with a high rate of pre-term birth. Am J Reprod Immunol 2008 ; 60 : 312–317. [CrossRef] [PubMed]
  37. Levrant S, Coulam CB, Jeyendran RS. Interleukin 1 receptor antagonist gene polymorphisms are not risk factors for recurrent pregnancy loss: evaluation of couples. Am J Reprod Immunol 2008 ; 60 : 224–228. [CrossRef] [PubMed]
  38. Ostojic S, Volk M, Medica I, et al. Polymorphisms in the interleukin-12/18 genes and recurrent spontaneous abortion. Am J Reprod Immunol 2007 ; 58 : 403–408. [CrossRef] [PubMed]
  39. Strakova Z, Mavrogianis P, Meng X, et al. In vivo infusion of interleukin-1beta and chorionic gonadotropin induces endometrial changes that mimic early pregnancy events in the baboon. Endocrinology 2005 ; 146 : 4097–4104. [CrossRef] [PubMed]
  40. Horai R, Asano M, Sudo K, et al. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 1998 ; 187 : 1463–1475. [CrossRef] [PubMed]
  41. Takeda K, Tsutsui H, Yoshimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998 ; 8 : 383–390. [CrossRef] [PubMed]
  42. Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 2006 ; 7 : 185–199. [CrossRef] [PubMed]
  43. Teklenburg G, Salker M, Heijnen C, et al. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod 2010 ; 16 : 886–895. [CrossRef] [PubMed]
  44. Zimmermann G, Ackermann W, Alexander H., Expression production of human chorionic gonadotropin (hCG) in the normal secretory endometrium: evidence of CGB7 and/or CGB6 beta hCG subunit gene expression. Biol Reprod 2012 ; 86 : 87. [CrossRef] [PubMed]
  45. Cole LA., hCG, the wonder of today’s science. Reprod Biol Endocrinol 2012 ; 10 : 24. [CrossRef] [PubMed]
  46. Perrier d’Hauterive S, Charlet-Renard C, Dubois M, et al. Du nouveau à l’interface materno-fœtale : rôle du couple hCG/récepteur LH-hCG dans l’implantation embryonnaire. Rev Med Liege 2006 ; 61 : 705–712. [PubMed]
  47. Bourdiec A, Bedard D, Rao CV, Akoum A. Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation, migration and the release of angiogenic factors. Am J Reprod Immunol 2013 ; 70 : 127–138. [CrossRef] [PubMed]
  48. Herrmann-Lavoie C, Rao CV, Akoum A. Chorionic gonadotropin down-regulates the expression of the decoy inhibitory interleukin 1 receptor type II in human endometrial epithelial cells. Endocrinology 2007 ; 148 : 5377–5384. [CrossRef] [PubMed]
  49. Bourdiec A, Calvo E, Rao CV, Akoum A., Transcriptome analysis reveals new insights into the modulation of endometrial stromal cell receptive phenotype by embryo-derived signals interleukin-1, human chorionic gonadotropin: possible involvement in early embryo implantation. PLoS One 2013 ; 8 : e64829. [CrossRef] [PubMed]
  50. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010 ; 63 : 601–610. [CrossRef] [PubMed]
  51. Lee JY, Lee M, Lee SK. Role of endometrial immune cells in implantation. Clin Exp Reprod Med 2011 ; 38 : 119–125. [CrossRef] [PubMed]
  52. Tsampalas M, Gridelet V, Berndt S, et al. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol 2010 ; 85 : 93–98. [CrossRef] [PubMed]
  53. Ledee N, Petitbarat M, Rahmati M, et al. New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side. J Reprod Immunol 2011 ; 88 : 118–123. [CrossRef] [PubMed]
  54. Petitbarat M, Rahmati M, Serazin V, et al. TWEAK, appears as a modulator of endometrial IL-18 related cytotoxic activity of uterine natural killers. PLoS One 2011 ; 6 : e14497. [CrossRef] [PubMed]
  55. Stampalija T, Chaiworapongsa T, Romero R, et al. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. J Matern-Fetal Neonatal Med 2013 ; 26 : 1359–1370. [CrossRef]
  56. Kaitu’u-Lino TJ, Tuohey L, Tong S. Maternal serum interleukin-33 and soluble ST2 across early pregnancy, and their association with miscarriage. J Reprod Immunol 2012 ; 95 : 46–49. [CrossRef] [PubMed]
  57. Salker MS, Nautiyal J, Steel JH, et al. Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One 2012 ; 7 : e52252. [CrossRef] [PubMed]
  58. Hu WT, Li MQ, Liu W, et al. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-kappaB and ERK1/2 signaling. Mol Hum Reprod 2014 ; 20 : 358–372. [CrossRef] [PubMed]
  59. Coulombel L. Tolérance maternelle du fœtus : le rôle d’un enhancer de Foxp3 lors de l’émergence des mammifères euthériens. Med Sci (Paris) 2012 ; 28 : 826–828. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.